Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Cost-Effectiveness of Semaglutide for Secondary Prevention of Cardiovascular Disease in US Adults.
Journal: JAMA cardiology
Published: February 04, 2026
Cardiovascular-Kidney-Metabolic Medication Eligibility Across National Survey, Community-Based, and Ambulatory Healthcare Samples.
Journal: JAMA cardiology
Published: January 28, 2026
Cardiometabolic Health of Low- and Higher-Income Adults in the United States, 2009-2023.
Journal: American heart journal
Published: November 17, 2025
Cardiometabolic health of low- and higher-income adults in the United States, 2009-2023.
Journal: American heart journal
Published: November 17, 2025
Discontinuation of Semaglutide Among Older Adults With Diabetes in the US and Japan.
Journal: JAMA cardiology
Published: September 24, 2025
The Limitations and Risks Associated With Semaglutide Treatment-Reply.
Journal: JAMA cardiology
Published: May 14, 2025
Semaglutide Eligibility Across All Current Indications for US Adults.
Journal: JAMA cardiology
Published: November 18, 2024
Showing 1-8 of 8
Last Updated: 09/26/2026